Channel Therapeutics Corp

Ownership Transactions Reported by 16 Insiders

Symbol
CHRO on NYSE
Location
685 Us Highway One, North Brunswick, NJ

There are no Buy or Sell transactions made by insiders since 10/17/2024

Channel Therapeutics Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Todd C. Davis Director $15.3M Jul 2, 2025
Ligand Pharmaceuticals Inc 10%+ Owner $15M Jul 1, 2025
Motif Pharmaceuticals Ltd. 10%+ Owner $2.26M Feb 15, 2024
Boswell Prayer Ltd. 10%+ Owner $2.21M Feb 15, 2024
Aperture Healthcare Ventures Ltd. 10%+ Owner $2.05M Feb 15, 2024
AME Equities LLC 10%+ Owner $1.69M Feb 15, 2024
Ezra Friedberg Director $1.48M Jul 2, 2025
Richard Malamut Director $199K Jul 2, 2025
Francis Knuettel II CFO, Treas & Secty $114K Jul 2, 2025
Chia-Lin Simmons Director Apr 11, 2025
Eric Lang Chief Medical Officer Jun 14, 2024
Richard Baxter Director Jul 2, 2025
Peter Greenleaf Director Jul 2, 2025
Scott M. Plesha CEO and President, Director Jul 2, 2025
Sai Rangarao Chief Commercial Officer Jul 2, 2025
Matthew Pauls Director Jul 2, 2025

Recent Insider Transactions by Companies or Individuals for Channel Therapeutics Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.